Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 13.83
(2.07%)
CNY 13.83
(2.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 107.26 Million | 148.45 Million | 110.26 Million | 66.67 Million | 98.27 Million | 89.55 Million |
| Net Income | 93.47 Million | 109.89 Million | 109.53 Million | 96.57 Million | 93.28 Million | 91.91 Million |
| Depreciation & Amortization | 20.61 Million | 18.04 Million | 16.13 Million | 9.84 Million | 5.18 Million | 4.6 Million |
| Deferred income taxes | -2.05 Million | -162.5 Thousand | -1.26 Million | 415.26 Thousand | -283.83 Thousand | - |
| Stock-based compensation | -4.34 Million | 1.49 Million | 7.78 Million | - | - | - |
| Change in working capital | 20.52 Million | 29.01 Million | 4.95 Million | -35.62 Million | 1.08 Million | -8.34 Million |
| Other non-cash items | -11.94 Million | -8.49 Million | -20.35 Million | -4.12 Million | -1.27 Million | 1.37 Million |
| Investing Cash Flow | -739.71 Million | -373.03 Million | 252.56 Million | -404.25 Million | -44.55 Million | -94.79 Million |
| Investments in PPE | -178.47 Million | -84.18 Million | -67.57 Million | -21.27 Million | -46.24 Million | -95.98 Million |
| Acquisitions | 52.75 Thousand | 557.52 | 7.85 Million | 21.29 Million | 46.64 Million | 75 Thousand |
| Investment purchases | -2.03 Billion | -2 Billion | -1.39 Billion | -915.67 Million | -200.9 Million | -10 Million |
| Sales/Maturities of investments | 1.47 Billion | 1.71 Billion | 1.69 Billion | 532.67 Million | 202.19 Million | 10.11 Million |
| Other Investing Activities | -561.23 Million | 0.36 | 9.58 Million | -21.27 Million | -46.24 Million | 1 Million |
| Financing Cash Flow | -54.31 Million | 618.11 Million | -83.3 Million | 439.7 Million | -8.35 Million | -61.64 Million |
| Debt repayment | -1.61 Million | -1.24 Million | -788.01 Thousand | - | -8.3 Million | -8.3 Million |
| Dividends payments | -52.69 Million | -74.46 Million | -82.51 Million | - | -356.23 Thousand | -69.64 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -12.3 Million | - | - |
| Other Financing Activities | -1.61 Million | 692.57 Million | -788.01 Thousand | 439.7 Million | 300 Thousand | 8 Million |
| Accounts receivables | 39.22 Million | 9.27 Million | 19.96 Million | -22.79 Million | 8.05 Million | -19.47 Million |
| Accounts payables | -23.05 Million | 17.98 Million | -5.63 Million | 1.31 Million | -4.99 Million | - |
| Inventory | 11.71 Million | 1.91 Million | -8.11 Million | -14.56 Million | -1.69 Million | 1.47 Million |
| Other working capital | -7.34 Million | -162.5 Thousand | -1.26 Million | 415.26 Thousand | -283.83 Thousand | -9.82 Million |
| Cash at beginning of period | 875.35 Million | 481.76 Million | 202.23 Million | 100.1 Million | 54.74 Million | 121.63 Million |
| Cash at end of period | 191.59 Million | 875.29 Million | 481.76 Million | 202.23 Million | 100.1 Million | 54.74 Million |
| Capital Expenditure | -178.47 Million | -84.18 Million | -67.57 Million | -21.27 Million | -46.24 Million | -95.98 Million |
| Effect of forex changes on cash | - | - | - | -0.57 | -0.23 | 0.83 |
| Net cash flow / Change in cash | -683.76 Million | 393.53 Million | 279.53 Million | 102.12 Million | 45.35 Million | -66.88 Million |
| Free Cash Flow | -71.2 Million | 64.27 Million | 42.69 Million | 45.39 Million | 52.02 Million | -6.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 24.99 Million | 18.51 Million | 21.47 Million | 93.47 Million | 31.67 Million | 20.28 Million |
| Depreciation & Amortization | 5.68 Million | 5.68 Million | 5.45 Million | 20.61 Million | -9.5 Million | 4.85 Million |
| Deferred income taxes | - | - | - | -2.05 Million | - | -772.06 Thousand |
| Stock-based compensation | - | - | -4.34 Million | -4.34 Million | - | - |
| Change in working capital | - | - | 43.58 Million | 20.52 Million | -45.18 Million | 45.18 Million |
| Other non-cash items | 2.19 Million | 10.19 Million | 9.96 Million | -11.94 Million | 58.63 Million | -1.57 Million |
| Investing Cash Flow | -182.8 Million | 59.95 Million | -185.92 Million | -739.71 Million | 186.21 Million | -48.03 Million |
| Investments in PPE | -38.01 Million | -54.07 Million | -43.86 Million | -178.47 Million | -52.53 Million | -51.11 Million |
| Acquisitions | 595.00 | - | 51.8 Thousand | 52.75 Thousand | 940.97 | 0.98 |
| Investment purchases | -771.82 Million | -496.96 Million | -353.45 Million | -2.03 Billion | -85.61 Million | -419.56 Million |
| Sales/Maturities of investments | 627.04 Million | 611 Million | 208.33 Million | 1.47 Billion | 324.36 Million | 425.64 Million |
| Other Investing Activities | 595.00 | 114.03 Million | 3 Million | -561.23 Million | -940.11 | -2.99 Million |
| Financing Cash Flow | -22.81 Million | -3.47 Million | 2.38 Million | -54.31 Million | -2.13 Million | -51.94 Million |
| Debt repayment | - | - | - | -1.61 Million | - | - |
| Dividends payments | - | - | - | -52.69 Million | -1.89 Million | -50.8 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -18.87 Million | -3.47 Million | 56.7 Million | -1.61 Million | -237.93 Thousand | -51.94 Million |
| Accounts receivables | - | - | 39.22 Million | 39.22 Million | -41.27 Million | 41.27 Million |
| Accounts payables | - | - | - | -23.05 Million | - | - |
| Inventory | - | - | 11.71 Million | 11.71 Million | -3.91 Million | 3.91 Million |
| Other working capital | - | - | -7.34 Million | -7.34 Million | - | - |
| Cash at beginning of period | 273.78 Million | 191.59 Million | 349.15 Million | 875.35 Million | 126.4 Million | 203.59 Million |
| Cash at end of period | 92.67 Million | 273.78 Million | 191.59 Million | 191.59 Million | 346.09 Million | 126.4 Million |
| Capital Expenditure | -38.01 Million | -54.07 Million | -43.86 Million | -178.47 Million | -52.53 Million | -51.11 Million |
| Effect of forex changes on cash | - | - | - | - | 0.60 | 0.37 |
| Net cash flow / Change in cash | -181.11 Million | 82.19 Million | -157.55 Million | -683.76 Million | 219.69 Million | -77.19 Million |
| Free Cash Flow | -16.51 Million | -25.36 Million | -17.88 Million | -71.2 Million | -16.92 Million | -28.32 Million |
GREEN
COENF
8442
8860
SONG
NIOCF